Skip to content

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform:
Publications

man working - Alto publications hero

Leveraging clinical and biological insights to drive innovation in psychiatry

See our publications, presentations, and more to discover the revolutionary potential of our precision approach.

Choose Resource Type
Choose Focus Area
Search Resources

Found 47 Results

April 7, 2018

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

April 1, 2018

ARTIST: A fully automated artifact rejection algorithm for single-pulse TMS-EEG data

July 18, 2017

Selective Effects of Psychotherapy on Frontopolar Cortical Function in PTSD

July 18, 2017

PTSD Psychotherapy Outcome Predicted by Brain Activation During Emotional Reactivity and Regulation

June 26, 2017

The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects

October 21, 2016

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

February 26, 2016

Sustained efficacy of agomelatine 10 mg, 25 mg, and 25-50 mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months

«...3 4 567 »

650 Castro Street, Suite 450
Mountain View, CA 94041

Company

About
Leadership
Careers
Contact

Science

Platform
Publications
Pipeline

Investors

Overview
News
Events & Presentations
Stock Info
SEC Filings
Corporate Governance
Resources

Privacy Policy
Terms of Use
Accessibility
Cookie Policy

© 2024 Alto Neuroscience Inc. All rights reserved.

Scroll to Top